Changes in iOS in IPF
This study is about a lung condition called Idiopathic Pulmonary Fibrosis (IPF), where scars build up in the lungs, making them stiff and harder to breathe. We usually use breathing tests to check lung health, but these can be difficult for some people with IPF. This can sometimes mean they don't get the right treatment. We're looking at a different test called impulse oscillometry (iOS). It uses sound waves to gently check how stiff the lungs are. This test has worked well for children, and we want to see if it can give better information about IPF in adults. We hope it will help us understand how the disease is progressing and predict important health changes, leading to better care.
At a glance
What is this study about?
Idiopathic Pulmonary Fibrosis (IPF) is a lung condition where scar tissue forms, making the lungs stiff and making it harder to get oxygen. This often leads to breathlessness, which can make everyday activities difficult. Currently, doctors use special breathing tests to see how well your lungs are working. These tests help decide when to start or change medications.
However, people with IPF have told us that these breathing tests can be quite hard to do. They can cause coughing and make people feel even more breathless. Unfortunately, about one in five people with IPF can't do these tests accurately. This is a problem because it could mean some people don't get the right medicine, or their medicine is stopped too soon when it might still be helping.
This study wants to explore a new way to check lung health called impulse oscillometry (iOS). This test uses gentle sound waves to measure how stiff your lungs are. It's a bit like gently tapping a hollow object to hear how it sounds, giving clues about what's inside. This method has been successful in children who find standard breathing tests difficult. We want to see if using iOS can give us clearer and easier-to-get information about how IPF is affecting people's lungs, both now and in the future.
Key takeaways
- We're studying a new lung test (iOS) for people with IPF.
- Current lung tests can be difficult for some people with IPF.
- iOS uses sound waves to measure lung stiffness, potentially making monitoring easier.
- The study aims to see if iOS can predict how IPF might change over time.
- No new medications are involved; it's about better ways to measure lung health.
- This research hopes to improve how IPF is monitored and managed in the future.
Who may be eligible?
To join this study, we are looking for adults between 18 and 100 years old, both men and women, who have been officially diagnosed with Idiopathic Pulmonary Fibrosis (IPF) by a team of specialists following international guidelines. You also need to be able to understand the study and willingly agree to take part by signing a consent form.
There are some reasons why you might not be able to join. For example, if you have other medical conditions that would make it unsafe to do certain lung tests, such as untreated tuberculosis, coughing up blood, a collapsed lung, or an unstable heart condition. If you've recently had major surgery (like on your eyes, chest, or tummy), or have certain types of aneurysms (swelling in a blood vessel), or are very unwell with a current infection, you wouldn't be able to participate.
Also, if you are unable to form a good seal around a mouthpiece for the breathing tests, you wouldn't be able to take part. This ensures we can get accurate measurements from everyone in the study.
- I have been officially diagnosed with Idiopathic Pulmonary Fibrosis (IPF) by specialists.
- I am an adult, between 18 and 100 years old.
- I can understand what the study is about and wish to participate.
- I don't have any major health issues (like recent surgery or an unstable heart condition) that would make lung tests unsafe.
- I can form a good seal around a mouthpiece for breathing tests.
This is a guide only — the research team will confirm whether you can take part.
What does participation involve?
The detailed involvement for this study isn't fully described in the information provided. However, generally, taking part in a study like this might involve a series of visits to a clinic at different times over a period. During these visits, you would likely have the new impulse oscillometry (iOS) test, as well as the usual lung function tests that your doctors already use. You might also be asked to share your own thoughts on how your condition is changing. There are no new medications given as part of this study, as it focuses on testing a new way to measure lung health. The total duration of your participation would depend on how long we need to track changes in your lung health to gather useful information.
Potential risks and benefits
Locations (1)
- Royal Brompton and Harefield hospitalsLondon, United Kingdom
Common questions
What is Idiopathic Pulmonary Fibrosis (IPF)?
IPF is a lung condition where scar tissue builds up in your lungs, making them stiff and harder to breathe. 'Idiopathic' means we don't know why it starts.
What is impulse oscillometry (iOS)?
It's a gentle test that uses sound waves to check how stiff your lungs are. It's different from the usual breathing tests and may be easier to do for some people.
Will taking part change my current medication?
No, this study is about evaluating a new measurement tool, not new medications. Your current treatment plan will continue as decided by your doctors.
How long will I be involved in the study?
The information provided doesn't specify the exact duration. Typically, studies like this involve several visits over a period, chosen to track changes in your condition effectively.
Is the iOS test painful?
No, the iOS test is usually gentle and not painful. It involves breathing normally through a mouthpiece while sound waves are sent into your lungs.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.